ONCS

ONCS

Last Updated:

OncoSec Medical

OncoSec is a San Diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. Through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients.

Our technology, ImmunoPulse™, is designed to enhance the local delivery and uptake of DNA-based immune-targeting agents, such as IL-12. Clinical trials of ImmunoPulse™ IL-12 demonstrated a favorable safety profile and evidence of anti-tumor activity in the treatment of various skin cancers as well as the potential to initiate a systemic immune response. Our lead program, ImmunoPulse™ IL-12, is currently in Phase II development for several indications, including metastatic melanoma, squamous cell carcinoma of the head and neck, and triple-negative breast cancer. To date, study results have laid the groundwork for the expansion into new DNA-encoded therapeutic candidates and tumor indications.

We are witnessing the emergence of a new vision in the immunotherapy landscape – one that can capitalize on the ability of local therapy to drive a systemic anti-tumor immune response and overcome some of the limitations of traditional treatments. At OncoSec, we are advancing a new generation of cancer therapies that we hope will result in clinically meaningful benefits to patients who have limited or no available treatment options.

Cash

Burn Rate (Qtr)

Pipeline Information

Click drug data to see upcoming trial info and prior data

Drug | Disease

Stage | Exp Date

Prior Data

TAVO + pembrolizumab

Triple Negative Breast Cancer (TNBC)

Phase 2 Data

TBD

TAVO™ (Tavokinogene telseplasmid) +pembrolizumab

Metastatic Melanoma

Submission of BLA for Accelerated Approval

2021

CORVax12 (TAVO + SARS-CoV-2 spike glycoprotein)

COVID-19 Vaccine

Phase 1

TBD

Recent Posts

See What The Community Is Saying - Click To See Full Post

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon